This product is currently not available for purchase.


Antidiabetics Market Forecast - Product Image

Antidiabetics Market Forecast

  • ID: 1088131
  • September 2010
  • Datamonitor
1 of 2

The antidiabetics market is expected to grow to $34.8 billion in 2019 for the seven major markets. Januvia will become the leading franchise from 2012 after patent expiry of Actos, with franchise sales reaching nearly $6 billion by 2019. Pipeline candidates will make up 30% of sales in 2019, with once-weekly GLP-1 agonists and new long-acting insulin analogs meeting success.

Reasons to Purchase

- Quantify the future size of the antidiabetics market from 2010-2019 and identify opportunities for new products
- Examine the future performance of leading antidiabetic brands and the growth of generics and insulin biosimilars
- Understand the barriers to uptake for novel antidiabetic agents

Note: Product cover images may vary from those shown
2 of 2
Note: Product cover images may vary from those shown


If you have a more general question about our products please try our


Our Clients

  • Pfizer, Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S